IL33 and obstructive sleep apnea syndrome: There was a higher prevalence of stage III periodontitis and severe OSA, as well as higher levels of periodontal parameters (PI and BOP), and expression of IL-1β and IL-6 in saliva and IL-6, IL-17A, and IL-33 in GCF, in patients with periodontitis and OSA.